Cargando…

Commentary: Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy?

Detalles Bibliográficos
Autores principales: Fargeas, Christine A., Lorico, Aurelio, Corbeil, Denis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406637/
https://www.ncbi.nlm.nih.gov/pubmed/34476215
http://dx.doi.org/10.3389/fonc.2021.712358
_version_ 1783746536263385088
author Fargeas, Christine A.
Lorico, Aurelio
Corbeil, Denis
author_facet Fargeas, Christine A.
Lorico, Aurelio
Corbeil, Denis
author_sort Fargeas, Christine A.
collection PubMed
description
format Online
Article
Text
id pubmed-8406637
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84066372021-09-01 Commentary: Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy? Fargeas, Christine A. Lorico, Aurelio Corbeil, Denis Front Oncol Oncology Frontiers Media S.A. 2021-08-12 /pmc/articles/PMC8406637/ /pubmed/34476215 http://dx.doi.org/10.3389/fonc.2021.712358 Text en Copyright © 2021 Fargeas, Lorico and Corbeil https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Fargeas, Christine A.
Lorico, Aurelio
Corbeil, Denis
Commentary: Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy?
title Commentary: Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy?
title_full Commentary: Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy?
title_fullStr Commentary: Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy?
title_full_unstemmed Commentary: Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy?
title_short Commentary: Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy?
title_sort commentary: could we address the interplay between cd133, wnt/β-catenin, and tert signaling pathways as a potential target for glioblastoma therapy?
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406637/
https://www.ncbi.nlm.nih.gov/pubmed/34476215
http://dx.doi.org/10.3389/fonc.2021.712358
work_keys_str_mv AT fargeaschristinea commentarycouldweaddresstheinterplaybetweencd133wntbcateninandtertsignalingpathwaysasapotentialtargetforglioblastomatherapy
AT loricoaurelio commentarycouldweaddresstheinterplaybetweencd133wntbcateninandtertsignalingpathwaysasapotentialtargetforglioblastomatherapy
AT corbeildenis commentarycouldweaddresstheinterplaybetweencd133wntbcateninandtertsignalingpathwaysasapotentialtargetforglioblastomatherapy